Key statistics
On Thursday, Akoya Biosciences Inc (AKYA:NSQ) closed at 2.89, 53.72% above the 52 week low of 1.88 set on May 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.00 |
---|---|
High | 3.06 |
Low | 2.88 |
Bid | 2.20 |
Offer | 2.89 |
Previous close | 3.03 |
Average volume | 167.91k |
---|---|
Shares outstanding | 49.50m |
Free float | 26.33m |
P/E (TTM) | -- |
Market cap | 149.98m USD |
EPS (TTM) | -1.22 USD |
Data delayed at least 15 minutes, as of Oct 10 2024 21:00 BST.
More ▼
Announcements
- Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
- Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors
- Akoya Biosciences Reports Second Quarter 2024 Financial Results
- Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
- Akoya Biosciences Reports First Quarter 2024 Financial Results
- Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
- Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
- Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
- Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
- Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
More ▼